When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?

Journal of Asthma

Volumn 45, Issue 6, 2008, Pages 479-483

  Sposato, Bruno ^a,c   Mariotta, Salvatore ^b   Ricci, Alberto ^b  

^a MISERICORDIA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UO Pneumologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ANALYTIC METHOD; ARTICLE; ASTHMA; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; REVERSIBILITY TEST; SPIROMETRY; SYMPTOM;

ADRENERGIC BETA-AGONISTS; ADULT; AIRWAY RESISTANCE; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; VITAL CAPACITY;

EID: 46949107823     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802069125     Document Type: Article

References (19)

1. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention. Washington, DC: National Heart, Lung and Blood Institute, 2002 (publication 02-3659).
2. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003; 58 (suppl 1):1-94.
3. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218.
4. Quanjer PH, Tammeling GJ, Cotes FE, Pedersen OF, Peslin R, Yernault JC. Standardized lung function testing. Eur Respir J 1993; 6 (suppl 16):1-99.
5. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. http://www.nhlbi.nih.gov/guidelines/asthma/.
6. Mariotta S, Sposato B, Ricci A, Bruno P, Mannino F. Test of reversibility in the early stages of bronchial asthma. J Asthma 2005; 42:487-491.
7. Galant SP, Morphew T, Amaro S, Liao O. Value of the bronchodilator response in assessing controller naïve asthmatic children. J Pediatrics 2007; 151:457-462.
8. Bjermer L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001; 95:703-719.
9. Quanjer PH, Dalhuijsen A, Van Zomeren BC. Summary equations of reference value. Bull Eur Physiopatol Respir 1983; 19(suppl 5):45-51.
10. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusion and recommendations of a Working party of the European Respiratory Society. Eur Respir J 1997; 24(suppl):2S-8S.
11. Shim C. Response to bronchodilators. Clin Chest Med 1989; 10:155-164.
12. Zomeren BC. Changing relationship between stature and lung volume during puberty. Respir Physiol 1986; 65:139-153.
13. Seely JE, Guzman CA, Becklake MR. Heart and lung function at rest and during exercise in adolescence. J Appl Physiol 1974; 36:34-40.
14. Alcock SM, Mamun M, Prescott RJ, Connoly CK. Symptoms and pulmonary function in asthma. Respir Med 1998; 92:849-857.
15. Bijl-Hofland ID, Cloostermann SG, Fogering HT, Akkermans RP, van Schayck CP. Relation of the perception of airway obstruction to the severity of asthma Thorax 1999; 54:15-19.
16. Malakauskas K, Sitkauskiene B, Stravinskaite K, Sakalauskas R. Dyspnea perception and reversibility of methacholine-induced unlimited airway narrowing in asthmatics. J Asthma 2006; 43:463-467.
17. Marseglia GL, Cirillo I, Vizzacaro A, Klersly C, Tosca MA, La Rosa M, Marseglia A, Licari A, Leone M, Ciprandi G. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 2007; 28:74-78.
18. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141:584-588.
19. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bair TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100:44-51.